Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.33 |
| ▸ | MEN1 | O00255 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 4/20 | 0.31 |
| ▸ | MAOA | P21397 | 3/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20222656 | 0.98 | KMT2A (0.33) | KMT2AMEN1MAPTALDH1A1HPGD | |
| SCHEMBL20222639 | 0.98 | KMT2A (0.31) | KMT2AMEN1MAPTALDH1A1HPGD | |
| SCHEMBL20222680 | 0.95 | KMT2A (0.36) | KMT2AMEN1MAPTALDH1A1HPGD | |
| SCHEMBL20222691 | 0.93 | KMT2A (0.35) | KMT2AMEN1MAPTALDH1A1HPGD | |
| SCHEMBL20845081 | 0.90 | MEN1 (0.31) | KMT2AMEN1MAPTALDH1A1HPGD | |
| SCHEMBL20222685 | 0.89 | DHODH (0.38) | KMT2AMEN1MAPTALDH1A1HPGD | |
| SCHEMBL20222641 | 0.89 | DHODH (0.38) | KMT2AMEN1MAPTALDH1A1HPGD | |
| SCHEMBL20222582 | 0.89 | AHR (0.35) | KMT2AMEN1MAPTALDH1A1HPGD | |
| SCHEMBL20222640 | 0.89 | CYP2C9 (0.38) | KMT2AMEN1MAPTALDH1A1HPGD | |
| SCHEMBL20222642 | 0.89 | CYP3A4 (0.36) | KMT2AMEN1MAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10693077-B2 | Compound and organic electronic device using the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2020-06-23 | — | — | US | disclosed |
| US-20180155312-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10693077-B2 | Compound and organic electronic device using the same | SOD1, SCO2, RCOR3 | KMT2A 1209/4885MEN1 2385/4885MAPT 3350/4885 |
| US-20180155312-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | SOD1, SCO2, RCOR3 | KMT2A 1209/4885MEN1 2385/4885MAPT 3350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.